Found 19 matching trials
Recurrent Stroke Prevention Clinical Outcome Study
PHASE41. Objectives and Hypothesis
1. Objectives:
This study evaluates...
Location
Jichi Medical Univercity
Genetic Epidemiology of Responses to Antihypertensives
N/ATo determine whether measured variation in genes coding for components of v...
Candesartan Effect in Second Stage Arterial Hypertension
PHASE4To compare the changes in mean sitting DBP from baseline after 4 weeks of t...
Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo
PHASE3The aim is to compare the blood pressure lowering effect of the combination...
Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe Hypertension
PHASE4The purpose of this study is to see if Candesartan, once daily (QD), added ...
Location
Multiple Locations
The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial
PHASE2The purpose of this study is to examine the effects of blood pressure medic...
Location
University of Southern California
ACEI or ARB and COVID-19 Severity and Mortality in US Veterans
N/ASevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus res...
Location
University of Utah
A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323
PHASE1This study is required to confirm the suitability of a candidate FDC of 16m...
Location
GSK Investigational Site
Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.
PHASE4Angiotensin receptor antagonists (ARA), beta-blockers and diuretics do not ...
Location
Institut de Recherches Cliniques de Montréal
Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo
PHASE2The purpose of this study is to investigate the effect of a 12-week candesa...
Location
Umeå University Hospital